speb/financial-data huggingface dataset:
CYAB income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -2446000.00
CYAB income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -2446000.00
CYAB cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2446000.00
CYAB income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -2446000.00
CYAB income_statement (quarterly, 2025-06-30) — Net Interest Income: 992000.00
CYAB cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -361000.00
CYAB cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -361000.00
CYAB income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 992000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Net PPE: 894000.00
CYAB cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -17000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -18655000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 587000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 587000.00
CYAB income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -3404000.00
CYAB income_statement (quarterly, 2025-06-30) — Normalized Income: -2446000.00
CYAB cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2560000.00
CYAB income_statement (quarterly, 2025-06-30) — Operating Income: -3419000.00
CYAB income_statement (quarterly, 2025-06-30) — Operating Revenue: 1331000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 14064191.00
CYAB balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 231000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 12290000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 520000.00
CYAB income_statement (quarterly, 2025-06-30) — Other Gand A: 1241000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Other Properties: 894000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Payables: 1780000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1780000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 1258000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 15268000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 15268000.00
CYAB income_statement (quarterly, 2025-06-30) — Pretax Income: -2427000.00
CYAB cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 1000.00
CYAB cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -17000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Receivables: 282000.00
CYAB income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 213000.00
CYAB income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 15000.00
CYAB cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -603000.00
CYAB income_statement (quarterly, 2025-06-30) — Research And Development: 1840000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 21000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -40314000.00
CYAB income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1456000.00
CYAB income_statement (quarterly, 2025-06-30) — Selling General And Administration: 2697000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Share Issued: 14064191.00
CYAB cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 866000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: -18655000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -33923000.00
CYAB income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CYAB income_statement (quarterly, 2025-06-30) — Tax Provision: 19000.00
CYAB income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.23
CYAB balance_sheet (quarterly, 2025-06-30) — Total Assets: 1611000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Total Capitalization: -18655000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Total Debt: 13083000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: -18655000.00
CYAB income_statement (quarterly, 2025-06-30) — Total Expenses: 4750000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 20266000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 894000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 1200000.00
CYAB income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -3419000.00
CYAB income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: -992000.00
CYAB cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -970000.00
CYAB balance_sheet (quarterly, 2025-06-30) — Working Capital: -18349000.00
CYAB income_statement (quarterly, 2025-09-30) — +Operating Expense: 3470000.00
CYAB income_statement (quarterly, 2025-09-30) — +Total Revenue: 1487000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1728000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 263000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 6962000.00
CYAB income_statement (quarterly, 2025-09-30) — Basic Average Shares: 13814167.00
CYAB income_statement (quarterly, 2025-09-30) — Basic EPS: -0.20
CYAB cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 204000.00
CYAB cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -19000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 719000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Capital Stock: 15270000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 0.00
CYAB balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 0.00
CYAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2496000.00
CYAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -18000.00
CYAB cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2692000.00
CYAB cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -35000.00
CYAB cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -19000.00
CYAB cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -66000.00
CYAB cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -588000.00
CYAB cash_flow (quarterly, 2025-09-30) — Change In Payable: -35000.00
CYAB cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -35000.00
CYAB cash_flow (quarterly, 2025-09-30) — Change In Receivables: 19000.00
CYAB cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -689000.00
CYAB cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 19000.00
CYAB cash_flow (quarterly, 2025-09-30) — Changes In Cash: -214000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -36091000.00
CYAB income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 175000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Current Assets: 534000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 363000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Current Debt: 14965000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 15328000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 2545000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 2545000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 21316000.00
CYAB cash_flow (quarterly, 2025-09-30) — Depreciation: 13000.00
CYAB cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 13000.00
CYAB cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 13000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 173000.00
CYAB income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 13814167.00
CYAB income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.20
CYAB income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2741000.00
CYAB income_statement (quarterly, 2025-09-30) — EBIT: -2158000.00
CYAB income_statement (quarterly, 2025-09-30) — EBITDA: -2145000.00
CYAB cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 31000.00
CYAB cash_flow (quarterly, 2025-09-30) — End Cash Position: 21000.00
CYAB cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2496000.00
CYAB cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2711000.00
CYAB income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 563000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Gross PPE: 803000.00
CYAB income_statement (quarterly, 2025-09-30) — Gross Profit: 1312000.00
CYAB cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 20000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Invested Capital: -21126000.00
CYAB cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -18000.00
CYAB cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CYAB cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 3043000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Line Of Credit: 43000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 356000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 356000.00
CYAB cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 3000000.00
CYAB cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -548000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Net Debt: 14965000.00
CYAB income_statement (quarterly, 2025-09-30) — Net Income: -2741000.00
CYAB income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2741000.00
CYAB income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2741000.00
CYAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2741000.00
CYAB income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2741000.00
CYAB cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2741000.00
CYAB income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2741000.00
CYAB income_statement (quarterly, 2025-09-30) — Net Interest Income: -582000.00
CYAB cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 2495000.00
CYAB cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 2452000.00
CYAB income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -582000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Net PPE: 803000.00
CYAB cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -18000.00
CYAB cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 0.00
CYAB balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -20823000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 315000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 315000.00
CYAB income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2145000.00
CYAB income_statement (quarterly, 2025-09-30) — Normalized Income: -2741000.00
CYAB cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -2692000.00
CYAB income_statement (quarterly, 2025-09-30) — Operating Income: -2158000.00
CYAB income_statement (quarterly, 2025-09-30) — Operating Revenue: 1487000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 14064191.00
CYAB balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 250000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 14922000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 454000.00
CYAB income_statement (quarterly, 2025-09-30) — Other Gand A: 563000.00
CYAB cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 113000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Other Properties: 803000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Payables: 1728000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1728000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 1261000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 15268000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 15268000.00
CYAB cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 0.00
CYAB income_statement (quarterly, 2025-09-30) — Pretax Income: -2740000.00
CYAB cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 1000.00
CYAB cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -19000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Receivables: 263000.00
CYAB income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 175000.00
CYAB income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 13000.00
CYAB cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -548000.00
CYAB income_statement (quarterly, 2025-09-30) — Research And Development: 1657000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 21000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -43055000.00
CYAB income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 1250000.00
CYAB income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1813000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Share Issued: 14064191.00
CYAB cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 448000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: -20823000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -36091000.00
CYAB income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CYAB income_statement (quarterly, 2025-09-30) — Tax Provision: 1000.00
CYAB income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
CYAB balance_sheet (quarterly, 2025-09-30) — Total Assets: 1337000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Total Capitalization: -20823000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Total Debt: 15684000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: -20823000.00
CYAB income_statement (quarterly, 2025-09-30) — Total Expenses: 3645000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 22160000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 803000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 844000.00
CYAB income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -2158000.00
CYAB income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 582000.00
CYAB cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: 164000.00
CYAB balance_sheet (quarterly, 2025-09-30) — Working Capital: -20782000.00
CYAB income_statement (annual, 2025-12-31) — +Operating Expense: 16811000.00
CYAB income_statement (quarterly, 2025-12-31) — +Operating Expense: 3702000.00
CYAB income_statement (annual, 2025-12-31) — +Total Revenue: 5707000.00
CYAB income_statement (quarterly, 2025-12-31) — +Total Revenue: 1629000.00
CYAB balance_sheet (annual, 2025-12-31) — Accounts Payable: 1775000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1775000.00
CYAB balance_sheet (annual, 2025-12-31) — Accounts Receivable: 269000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 269000.00
CYAB balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -152000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -152000.00
CYAB balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 7332000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7332000.00
CYAB income_statement (annual, 2025-12-31) — Basic Average Shares: 13814167.00
CYAB income_statement (annual, 2025-12-31) — Basic EPS: -0.93
CYAB cash_flow (annual, 2025-12-31) — Beginning Cash Position: 946000.00
CYAB cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 21000.00
CYAB cash_flow (annual, 2025-12-31) — Capital Expenditure: -55000.00
CYAB cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -7000.00
CYAB balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 648000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 648000.00
CYAB balance_sheet (annual, 2025-12-31) — Capital Stock: 15270000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Capital Stock: 15270000.00
CYAB balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 294000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 294000.00
CYAB balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 294000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 294000.00
CYAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 7597000.00
CYAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 1970000.00
CYAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -54000.00
CYAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -7000.00
CYAB cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -8144000.00
CYAB cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1619000.00
CYAB cash_flow (annual, 2025-12-31) — Change In Account Payable: 684000.00
CYAB cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 40000.00
CYAB cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 42000.00
CYAB cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 98000.00
CYAB cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -116000.00
CYAB cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 114000.00
CYAB cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 506000.00
CYAB cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 118000.00
CYAB cash_flow (annual, 2025-12-31) — Change In Payable: 684000.00
CYAB cash_flow (quarterly, 2025-12-31) — Change In Payable: 40000.00
CYAB cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 684000.00
CYAB cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 40000.00
CYAB cash_flow (annual, 2025-12-31) — Change In Receivables: -156000.00
CYAB cash_flow (quarterly, 2025-12-31) — Change In Receivables: -6000.00
CYAB cash_flow (annual, 2025-12-31) — Change In Working Capital: 960000.00
CYAB cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 364000.00
CYAB cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -156000.00
CYAB cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -6000.00
CYAB cash_flow (annual, 2025-12-31) — Changes In Cash: -601000.00
CYAB cash_flow (quarterly, 2025-12-31) — Changes In Cash: 344000.00
CYAB balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
CYAB balance_sheet (annual, 2025-12-31) — Common Stock Equity: -40039000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: -40039000.00
CYAB cash_flow (annual, 2025-12-31) — Common Stock Issuance: 2431000.00
CYAB income_statement (annual, 2025-12-31) — Cost Of Revenue: 866000.00
CYAB income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 282000.00
CYAB balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 476000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 476000.00
CYAB balance_sheet (annual, 2025-12-31) — Current Assets: 737000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Current Assets: 737000.00
CYAB balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 380000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 380000.00
CYAB balance_sheet (annual, 2025-12-31) — Current Debt: 18637000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Current Debt: 18637000.00
CYAB balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 19017000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 19017000.00
CYAB balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 2816000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 2816000.00
CYAB balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 2816000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 2816000.00
CYAB balance_sheet (annual, 2025-12-31) — Current Liabilities: 25476000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 25476000.00
CYAB cash_flow (annual, 2025-12-31) — Depreciation: 58000.00
CYAB cash_flow (quarterly, 2025-12-31) — Depreciation: 16000.00
CYAB cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 58000.00
CYAB cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 16000.00
CYAB cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 58000.00
CYAB cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 16000.00
CYAB balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 370000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 370000.00
CYAB income_statement (annual, 2025-12-31) — Diluted Average Shares: 13814167.00
CYAB income_statement (annual, 2025-12-31) — Diluted EPS: -0.93
CYAB income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -12819000.00
CYAB income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -4318000.00
CYAB income_statement (annual, 2025-12-31) — EBIT: -12305000.00
CYAB income_statement (quarterly, 2025-12-31) — EBIT: -2690000.00
CYAB income_statement (annual, 2025-12-31) — EBITDA: -12247000.00
CYAB income_statement (quarterly, 2025-12-31) — EBITDA: -2674000.00
CYAB cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -29000.00
CYAB cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -49000.00
CYAB cash_flow (annual, 2025-12-31) — End Cash Position: 316000.00
CYAB cash_flow (quarterly, 2025-12-31) — End Cash Position: 316000.00
CYAB cash_flow (annual, 2025-12-31) — Financing Cash Flow: 7597000.00
CYAB cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 1970000.00
CYAB cash_flow (annual, 2025-12-31) — Free Cash Flow: -8199000.00
CYAB cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -1626000.00
CYAB cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -1000.00
CYAB cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -1000.00
CYAB income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -181000.00
CYAB income_statement (annual, 2025-12-31) — General And Administrative Expense: 8967000.00
CYAB income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 5648000.00
CYAB balance_sheet (annual, 2025-12-31) — Gross PPE: 873000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Gross PPE: 873000.00
CYAB income_statement (annual, 2025-12-31) — Gross Profit: 4841000.00
CYAB income_statement (quarterly, 2025-12-31) — Gross Profit: 1347000.00
CYAB cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 21000.00
CYAB income_statement (annual, 2025-12-31) — Interest Expense: 493000.00
CYAB income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 493000.00
CYAB cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 94000.00
CYAB cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 17000.00
CYAB balance_sheet (annual, 2025-12-31) — Invested Capital: -21402000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Invested Capital: -21402000.00
CYAB cash_flow (annual, 2025-12-31) — Investing Cash Flow: -54000.00
CYAB cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -7000.00
CYAB cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 2431000.00
CYAB cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CYAB cash_flow (annual, 2025-12-31) — Issuance Of Debt: 7554000.00
CYAB cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2898000.00
CYAB balance_sheet (annual, 2025-12-31) — Leases: 21000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Leases: 21000.00
CYAB balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 268000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 268000.00
CYAB balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 268000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 268000.00
CYAB cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 7554000.00
CYAB cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2941000.00
CYAB cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2391000.00
CYAB cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -928000.00
CYAB balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 277000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 277000.00
CYAB cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 2431000.00
CYAB balance_sheet (annual, 2025-12-31) — Net Debt: 18343000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Net Debt: 18343000.00
CYAB cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 109000.00
CYAB income_statement (annual, 2025-12-31) — Net Income: -12819000.00
CYAB income_statement (quarterly, 2025-12-31) — Net Income: -4318000.00
CYAB income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -12819000.00
CYAB income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -4318000.00
CYAB income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -12819000.00
CYAB income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -4318000.00
CYAB income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -12819000.00
CYAB income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -4318000.00
CYAB income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -12819000.00
CYAB income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -4318000.00
CYAB cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -12819000.00
CYAB cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -4318000.00
CYAB income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -12819000.00
CYAB income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -4318000.00
CYAB income_statement (annual, 2025-12-31) — Net Interest Income: -647000.00
CYAB income_statement (quarterly, 2025-12-31) — Net Interest Income: -1781000.00
CYAB cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 5163000.00
CYAB cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 1970000.00
CYAB cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 5163000.00
CYAB cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 2013000.00
CYAB income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -647000.00
CYAB income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1781000.00
CYAB balance_sheet (annual, 2025-12-31) — Net PPE: 721000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Net PPE: 721000.00
CYAB cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -54000.00
CYAB cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -7000.00
CYAB cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CYAB cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -43000.00
CYAB balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -24771000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -24771000.00
CYAB balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 115000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 115000.00
CYAB balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 115000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 115000.00
CYAB income_statement (annual, 2025-12-31) — Normalized EBITDA: -12066000.00
CYAB income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2674000.00
CYAB income_statement (annual, 2025-12-31) — Normalized Income: -12679630.00
CYAB income_statement (quarterly, 2025-12-31) — Normalized Income: -4318000.00
CYAB cash_flow (annual, 2025-12-31) — Operating Cash Flow: -8144000.00
CYAB cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -1619000.00
CYAB cash_flow (annual, 2025-12-31) — Operating Gains Losses: 108000.00
CYAB income_statement (annual, 2025-12-31) — Operating Income: -11970000.00
CYAB income_statement (quarterly, 2025-12-31) — Operating Income: -2355000.00
CYAB income_statement (annual, 2025-12-31) — Operating Revenue: 5707000.00
CYAB income_statement (quarterly, 2025-12-31) — Operating Revenue: 1629000.00
CYAB balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 14064191.00
CYAB balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 14064191.00
CYAB balance_sheet (annual, 2025-12-31) — Other Current Assets: 81000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 81000.00
CYAB balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 18637000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 18637000.00
CYAB balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 94000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 94000.00
CYAB income_statement (annual, 2025-12-31) — Other Gand A: 2027000.00
CYAB income_statement (quarterly, 2025-12-31) — Other Gand A: -1292000.00
CYAB income_statement (annual, 2025-12-31) — Other Income Expense: -181000.00
CYAB cash_flow (annual, 2025-12-31) — Other Non Cash Items: 400000.00
CYAB cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 258000.00
CYAB balance_sheet (annual, 2025-12-31) — Other Properties: 575000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Other Properties: 575000.00
CYAB balance_sheet (annual, 2025-12-31) — Payables: 1775000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Payables: 1775000.00
CYAB balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 2251000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2251000.00
CYAB balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1298000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1298000.00
CYAB balance_sheet (annual, 2025-12-31) — Preferred Stock: 15268000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 15268000.00
CYAB balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 15268000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 15268000.00
CYAB balance_sheet (annual, 2025-12-31) — Prepaid Assets: 71000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 71000.00
CYAB income_statement (annual, 2025-12-31) — Pretax Income: -12798000.00
CYAB income_statement (quarterly, 2025-12-31) — Pretax Income: -4317000.00
CYAB cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 3000.00
CYAB cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CYAB balance_sheet (annual, 2025-12-31) — Properties: 0.00
CYAB balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CYAB cash_flow (annual, 2025-12-31) — Purchase Of PPE: -55000.00
CYAB cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -7000.00
CYAB balance_sheet (annual, 2025-12-31) — Receivables: 269000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Receivables: 269000.00
CYAB income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 866000.00
CYAB income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 282000.00
CYAB income_statement (annual, 2025-12-31) — Reconciled Depreciation: 58000.00
CYAB income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 16000.00
CYAB income_statement (annual, 2025-12-31) — Rent And Landing Fees: 116000.00
CYAB income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 116000.00
CYAB cash_flow (annual, 2025-12-31) — Repayment Of Debt: -2391000.00
CYAB cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -928000.00
CYAB income_statement (annual, 2025-12-31) — Research And Development: 6894000.00
CYAB income_statement (quarterly, 2025-12-31) — Research And Development: 1547000.00
CYAB balance_sheet (annual, 2025-12-31) — Restricted Cash: 22000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 22000.00
CYAB balance_sheet (annual, 2025-12-31) — Retained Earnings: -47373000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -47373000.00
CYAB income_statement (annual, 2025-12-31) — Salaries And Wages: 6824000.00
CYAB cash_flow (annual, 2025-12-31) — Sale Of PPE: 1000.00
CYAB cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
CYAB income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 950000.00
CYAB income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: -3493000.00
CYAB income_statement (annual, 2025-12-31) — Selling General And Administration: 9917000.00
CYAB income_statement (quarterly, 2025-12-31) — Selling General And Administration: 2155000.00
CYAB balance_sheet (annual, 2025-12-31) — Share Issued: 14064191.00
CYAB balance_sheet (quarterly, 2025-12-31) — Share Issued: 14064191.00
CYAB cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 0.00
CYAB cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: -43000.00
CYAB cash_flow (annual, 2025-12-31) — Stock Based Compensation: 3024000.00
CYAB cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 321000.00
CYAB balance_sheet (annual, 2025-12-31) — Stockholders Equity: -24771000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: -24771000.00
CYAB balance_sheet (annual, 2025-12-31) — Tangible Book Value: -40039000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -40039000.00
CYAB income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -41630.00
CYAB income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CYAB income_statement (annual, 2025-12-31) — Tax Provision: 21000.00
CYAB income_statement (quarterly, 2025-12-31) — Tax Provision: 1000.00
CYAB income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.23
CYAB income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.23
CYAB balance_sheet (annual, 2025-12-31) — Total Assets: 1458000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Total Assets: 1458000.00
CYAB balance_sheet (annual, 2025-12-31) — Total Capitalization: -24771000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Total Capitalization: -24771000.00
CYAB balance_sheet (annual, 2025-12-31) — Total Debt: 19285000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Total Debt: 19285000.00
CYAB balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: -24771000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: -24771000.00
CYAB income_statement (annual, 2025-12-31) — Total Expenses: 17677000.00
CYAB income_statement (quarterly, 2025-12-31) — Total Expenses: 3984000.00
CYAB balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 26229000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 26229000.00
CYAB balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 721000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 721000.00
CYAB balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 753000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 753000.00
CYAB income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -11970000.00
CYAB income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -2355000.00
CYAB income_statement (annual, 2025-12-31) — Total Other Finance Cost: 154000.00
CYAB income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 1288000.00
CYAB income_statement (annual, 2025-12-31) — Total Unusual Items: -181000.00
CYAB income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -181000.00
CYAB cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 125000.00
CYAB cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 1632000.00
CYAB balance_sheet (annual, 2025-12-31) — Working Capital: -24739000.00
CYAB balance_sheet (quarterly, 2025-12-31) — Working Capital: -24739000.00
CYAB income_statement (quarterly, 2026-03-31) — +Operating Expense: 13047000.00
CYAB income_statement (quarterly, 2026-03-31) — +Total Revenue: 1415000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2484000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 216000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 46093000.00
CYAB income_statement (quarterly, 2026-03-31) — Basic Average Shares: 3471031.00
CYAB income_statement (quarterly, 2026-03-31) — Basic EPS: -3.10
CYAB cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 316000.00
CYAB cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -5000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 559000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 3122000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 3122000.00
CYAB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 5624000.00
CYAB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -5000.00
CYAB cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -2598000.00
CYAB cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 709000.00
CYAB cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -25000.00
CYAB cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 2222000.00
CYAB cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1036000.00
CYAB cash_flow (quarterly, 2026-03-31) — Change In Payable: 709000.00
CYAB cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 709000.00
CYAB cash_flow (quarterly, 2026-03-31) — Change In Receivables: 53000.00
CYAB cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 3995000.00
CYAB cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 53000.00
CYAB cash_flow (quarterly, 2026-03-31) — Changes In Cash: 3021000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Common Stock: 2000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: -12048000.00
CYAB income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 192000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 4700000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Current Assets: 3772000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 390000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Current Debt: 2237000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2627000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 2288000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 2288000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 16365000.00
CYAB cash_flow (quarterly, 2026-03-31) — Depreciation: 14000.00
CYAB cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 14000.00
CYAB cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 14000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 0.00
CYAB income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 3471031.00
CYAB income_statement (quarterly, 2026-03-31) — Diluted EPS: -3.10
CYAB income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -10770000.00
CYAB income_statement (quarterly, 2026-03-31) — EBIT: -11824000.00
CYAB income_statement (quarterly, 2026-03-31) — EBITDA: -11810000.00
CYAB cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -22000.00
CYAB cash_flow (quarterly, 2026-03-31) — End Cash Position: 3315000.00
CYAB cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 5624000.00
CYAB cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -2603000.00
CYAB income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 6284000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Gross PPE: 630000.00
CYAB income_statement (quarterly, 2026-03-31) — Gross Profit: 1223000.00
CYAB income_statement (quarterly, 2026-03-31) — Interest Income: 1054000.00
CYAB income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1054000.00
CYAB cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 179000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Invested Capital: -9811000.00
CYAB cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -5000.00
CYAB cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 2655000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 169000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 169000.00
CYAB cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 2655000.00
CYAB cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -6370000.00
CYAB cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 32000.00
CYAB income_statement (quarterly, 2026-03-31) — Net Income: -10770000.00
CYAB income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -10770000.00
CYAB income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -10770000.00
CYAB income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -10770000.00
CYAB income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -10770000.00
CYAB cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -10770000.00
CYAB income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -10770000.00
CYAB income_statement (quarterly, 2026-03-31) — Net Interest Income: 1054000.00
CYAB cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -3715000.00
CYAB cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -3715000.00
CYAB income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1054000.00
CYAB cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 9336000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Net PPE: 630000.00
CYAB cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -5000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -12048000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 41000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 41000.00
CYAB income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -11810000.00
CYAB income_statement (quarterly, 2026-03-31) — Normalized Income: -10770000.00
CYAB cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -2598000.00
CYAB cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 32000.00
CYAB income_statement (quarterly, 2026-03-31) — Operating Income: -11824000.00
CYAB income_statement (quarterly, 2026-03-31) — Operating Revenue: 1415000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 14064191.00
CYAB balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 241000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 2237000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1322000.00
CYAB income_statement (quarterly, 2026-03-31) — Other Gand A: 6284000.00
CYAB cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 173000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 125000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Other Properties: 630000.00
CYAB income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CYAB balance_sheet (quarterly, 2026-03-31) — Payables: 2484000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 7184000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2944000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CYAB income_statement (quarterly, 2026-03-31) — Pretax Income: -10770000.00
CYAB cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 3000.00
CYAB cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -5000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Receivables: 216000.00
CYAB income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 192000.00
CYAB income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 14000.00
CYAB cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -6370000.00
CYAB income_statement (quarterly, 2026-03-31) — Research And Development: 5508000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 193000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -58143000.00
CYAB income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 1255000.00
CYAB income_statement (quarterly, 2026-03-31) — Selling General And Administration: 7539000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Share Issued: 14064191.00
CYAB cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 5217000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -12048000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -12048000.00
CYAB income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CYAB income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
CYAB income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
CYAB balance_sheet (quarterly, 2026-03-31) — Total Assets: 4527000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Total Capitalization: -12048000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Total Debt: 2796000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -12048000.00
CYAB income_statement (quarterly, 2026-03-31) — Total Expenses: 13239000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 16575000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 755000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 210000.00
CYAB income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -11824000.00
CYAB cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: -1259000.00
CYAB balance_sheet (quarterly, 2026-03-31) — Working Capital: -12593000.00
CYAD.BR balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 6317000.00
CYAD.BR cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 217000.00
CYAD.BR cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 0.00
CYAD.BR cash_flow (annual, 2021-12-31) — Capital Expenditure: -393000.00
CYAD.BR cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Financing Activities: 39521000.00
CYAD.BR cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Investing Activities: -126000.00
CYAD.BR cash_flow (annual, 2021-12-31) — Cash Flow From Continuing Operating Activities: -26643000.00